This study is a double-blind randomized controlled trial designed to establish the non-inferiority of Sci-B-Vac compared to Engerix-B® in adults ≥ 18 years old and the superiority of Sci-B-Vac™ compared to Engerix-B® in adults ≥ 45 years old. Study subjects will be randomized 1:1 to receive either a total of 3 injections of Sci-B-Vac™ or 3 injections of Engerix-B® intra-muscularly (IM) on Days 0, 28, and 168.
https://clinicaltrials.gov/ct2/show/NCT03393754?term=Sci-B-Vac-001&rank=1